LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biomaterials

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.biomaterials.2013.08.039PMID 24008043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Function of the Blood-Brain Barrier and Restriction of Drug Delivery to Invasive Glioma Cells: Findings in an Orthotopic Rat Xenograft Model of Glioma

  2013cited by this paper
• A tissue factor targeted nanomedical system for thrombi-specific drug delivery.

  2012cited by this paper
• Chemical optimization of new ligands of the low-density lipoprotein receptor as potential vectors for central nervous system targeting.

  2012cited by this paper
• Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy.

  2012cited by this paper
• Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles.

  2012cited by this paper
• Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery.

  2012cited by this paper
• The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.

  2012cited by this paper
• Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.

  2011cited by this paper
• Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.

  2011cited by this paper
• Could nanoparticle systems have a role in the treatment of cerebral gliomas?

  2011cited by this paper
• Imaging brain tumor by dendrimer-based optical/paramagnetic nanoprobe across the blood-brain barrier.

  2011cited by this paper
• A Carrier for Non-Covalent Delivery of Functional Beta-Galactosidase and Antibodies against Amyloid Plaques and IgM to the Brain

  2011cited by this paper
• Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain

  2011cited by this paper
• Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.

  2011cited by this paper
• Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes.

  2011cited by this paper
• Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.

  2010cited by this paper
• EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery.

  2010cited by this paper
• Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.

  2010cited by this paper
• Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations.

  2009cited by this paper
• Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.

  2009cited by this paper
• Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.

  2009cited by this paper
• Evaluation of human brain tumor heterogeneity using multiple T1‐based MRI signal weighting approaches

  2008cited by this paper
• Targeted delivery of proteins across the blood–brain barrier

  2007cited by this paper
• Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particles.

  2007cited by this paper
• Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.

  2007cited by this paper
• Angiogenesis in brain tumours

  2007cited by this paper
• Eisosomes mark static sites of endocytosis

  2006cited by this paper
• Drug penetration in solid tumours

  2006cited by this paper
• Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents.

  2006cited by this paper
• Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery.

  2005cited by this paper
• Molecular biology of the blood-brain barrier.

  2005cited by this paper
• Molecular biology of the blood-brain barrier

  2005cited by this paper
• Models of glycoprotein hormone receptor interaction

  2005cited by this paper
• MR and fluorescent imaging of low-density lipoprotein receptors.

  2004cited by this paper
• Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs.

  2004cited by this paper
• Peptide‐based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases

  2004cited by this paper
• Primary brain tumours in adults.

  2003cited by this paper
• Primary brain tumours in adults.

  2003cited by this paper
• Paclitaxel and its formulations.

  2002cited by this paper
• Synthesis of Pegylated Immunonanoparticles

  2002cited by this paper
• Therapeutic cancer targeting peptides.

  2002cited by this paper
• Epidemiology of primary brain tumors: current concepts and review of the literature.

  2002cited by this paper
• A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants

  2001cited by this paper
• The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery.

  2000cited by this paper
• Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein.

  2000cited by this paper
• The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts.

  2000cited by this paper
• A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade glioma.

  2000cited by this paper
• The mammalian low-density lipoprotein receptor family.

  1999cited by this paper
• Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes.

  1998cited by this paper
• A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier

  1997cited by this paper
• Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.

  1996cited by this paper
• Low-Density Lipoprotein as a Vehicle for Targeting Antitumor Compounds to Cancer Cells

  1994cited by this paper
• Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells.

  1994cited by this paper
• Clinical pharmacology of Taxol.

  1993cited by this paper
• Clinical pharmacology of Taxol.

  1993cited by this paper
• Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes

  1987cited by this paper
• Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.

  1987cited by this paper

• A new era in brain drug delivery: Integrating multivalency and computational optimisation for blood-brain barrier permeation.

  2025cites this paper
• Cholesterol-Conjugated Polyion Complex Nanoparticles for Combination Delivery of Hydrophobic Paclitaxel and Hydrophilic miR-34a for Colon Cancer Therapy

  2025cites this paper
• Drugs Based on Bioactive Oligopeptides

  2025cites this paper
• Development of simplified poly(β-aminoester)-zwitterion nanovehicles for controlled cancer cell transfection and enhanced gene delivery across a cell-based model of the blood-brain barrier

  2025cites this paper
• Combined Strategies for Nanodrugs Noninvasively Overcoming the Blood–Brain Barrier and Actively Targeting Glioma Lesions

  2025cites this paper
• Beyond the Walls of Troy: A Scoping Review on Pharmacological Strategies to Enhance Drug Delivery Across the Blood–Brain Barrier and Blood–Tumor Barrier

  2025cites this paper
• Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part I: receptor-mediated nose-to-brain delivery approaches for glioblastoma

  2025cites this paper
• Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting

  2025cites this paper
• Recent advances in nanomaterial-based brain-targeted delivery systems for glioblastoma therapy.

  2025cites this paper
• Inorganic nanoparticles and blood-brain barrier modulation: Advancing targeted neurological therapies.

  2025cites this paper
• Nanostructured lipid carriers for enhanced batimastat delivery across the blood–brain barrier: an in vitro study for glioblastoma treatment

  2025cites this paper
• Low-density lipoprotein receptor interacts with clusterin to regulate A1/A2 astrocyte polarization and ameliorate hemorrhagic brain injury.

  2025cites this paper
• Neutrophil/monocyte-targeted dual-ligands modified liposomes delivering puerarin for ischemia stroke treatment

  2025cites this paper
• Aptamers: ushering in new hopes in targeted glioblastoma therapy

  2024cites this paper
• Two-Photon Intravital Microscopy of Glioblastoma in a Murine Model.

  2024cites this paper
• Current advance of nanotechnology in diagnosis and treatment for malignant tumors

  2024cites this paper
• The multifaceted therapeutical role of low‐density lipoprotein receptor family in high‐grade glioma

  2024cites this paper
• A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective, and anti-inflammatory properties following status epilepticus in mice

  2024cites this paper
• Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke.

  2024cites this paper
• Ruxolitinib-loaded cytokine nanosponge alleviated the cytokine storm and dampened macrophage overactivation for the treatment of hemophagocytic lymphohistiocytosis.

  2024cites this paper
• Functionalized nanoparticles crossing the brain–blood barrier to target glioma cells

  2023cites this paper
• Customizing delivery nano-vehicles for precise brain tumor therapy

  2023cites this paper
• Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery

  2023cites this paper
• Visual Investigation of Tumor‐Promoting Fibronectin Potentiated by Obesity in Pancreatic Ductal Adenocarcinoma Using an MR/NIRF Dual‐Modality Dendrimer Nanoprobe

  2023cites this paper
• Low-Density Lipoprotein Pathway Is a Ubiquitous Metabolic Vulnerability in High Grade Glioma Amenable for Nanotherapeutic Delivery

  2023cites this paper
• Blood–brain barrier disruption in dementia: Nano‐solutions as new treatment options

  2023cites this paper
• Tailor-made nanocargoes as promising tool for brain targeting: Modulated approaches with better therapeutic outcomes

  2023cites this paper
• Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas.

  2023cites this paper
• Low-density lipoprotein: a versatile nanoscale platform for targeted delivery

  2023cites this paper
• Nucleic acid drug vectors for diagnosis and treatment of brain diseases

  2023cites this paper
• Nanotechnology-integrated ovarian cancer metastasis therapy: Insights from the metastatic mechanisms into administration routes and therapy strategies.

  2023cites this paper
• LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment

  2023cites this paper
• Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis

  2023cites this paper
• Sonophoresis-assisted transdermal delivery of antimigraine-loaded nanolipomers: Radio-tracking, histopathological assessment and in-vivo biodistribution study.

  2023cites this paper
• Innovative nanomaterials for cancer diagnosis, imaging, and therapy: Drug deliveryapplications

  2023cites this paper
• 2-(2-Cholesteroxyethoxyl)ethyl-3′-S-glutathionylpropionate (COXP) for brain-targeting liposomes

  2022cites this paper
• Bioinspired low-density lipoprotein co-delivery system for targeting and synergistic cancer therapy.

  2022cites this paper
• Current Update on Transcellular Brain Drug Delivery

  2022cites this paper
• Development of a Nanoparticle-Based Approach for the Blood–Brain Barrier Passage in a Murine Model of Amyotrophic Lateral Sclerosis

  2022cites this paper
• Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges

  2022cites this paper
• Getting drugs to the brain: advances and prospects of organic nanoparticle delivery systems for assisting drugs to cross the blood-brain barrier.

  2022cites this paper
• A green-inspired method to prepare non-split high-density lipoprotein (HDL) carrier with anti-dysfunctional activities superior to reconstituted HDL.

  2022cites this paper
• Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches

  2022cites this paper
• Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

  2022cites this paper
• Nanotechnology-Assisted Cell Tracking

  2022cites this paper
• Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases.

  2022cites this paper
• Targeting Zika Virus with New Brain- and Placenta-Crossing Peptide–Porphyrin Conjugates

  2022cites this paper
• Targeted Drug Delivery to the Central Nervous System Using Extracellular Vesicles

  2022cites this paper
• A D-peptide ligand of neuropeptide Y receptor Y1 serves as nanocarrier traversing of the blood brain barrier and targets glioma

  2022cites this paper
• Surface Engineered Dendrimers: A Potential Nanocarrier for the Effective Management of Glioblastoma Multiforme.

  2022cites this paper
• Enhanced proton treatment with a LDLR-ligand peptide-conjugated gold nanoparticles targeting the tumor microenvironment in an infiltrative brain tumor model.

  2022cites this paper
• Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors.

  2022cites this paper
• Nanotechnological advancements in the brain tumor therapy: a novel approach.

  2022cites this paper
• Enhancing autophagy in Alzheimer's disease through drug repositioning.

  2022cites this paper
• Penetrating the Blood-Brain Barrier with New Peptide–Porphyrin Conjugates Having anti-HIV Activity

  2021cites this paper
• LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications

  2021cites this paper
• Targeting of Drug Nanocarriers

  2021cites this paper
• 2-(2-Cholesteroxyethoxyl)ethyl 3'-S-glutathionylpropionate and Its Self-assembled Micelles for Brain Delivery: Design, Synthesis and Evaluation.

  2021cites this paper
• Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment

  2021cites this paper
• Dual-triggered biomimetic vehicles enable treatment of glioblastoma through a cancer stem cell therapeutic strategy.

  2021cites this paper
• LDL receptors and their role in targeted therapy for glioma: a review.

  2021cites this paper
• Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain

  2021cites this paper
• Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges

  2021cites this paper
• High-density lipoprotein in Alzheimer's disease: From potential biomarkers to therapeutics.

  2021cites this paper
• Targeting the blood-brain barrier for the delivery of stroke therapies.

  2021cites this paper
• Exploring the Therapeutic Potential of the Bioinspired Reconstituted High Density Lipoprotein Nanostructures.

  2021cites this paper
• Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential

  2021cites this paper
• Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain.

  2021cites this paper
• Drug Delivery Systems and Strategies to Overcome the Barriers of Brain.

  2021cites this paper
• Dual Blood-Brain Barrier-Glioma Targeting Peptide-Poly(levodopamine) Hybrid Nanoplatforms as Potential Near Infrared Phototheranostic Agents in Glioblastoma.

  2021cites this paper
• Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain

  2021cites this paper
• Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders.

  2021cites this paper
• Targeting to the CNS: Approach for brain tumor

  2021cites this paper
• LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma

  2021cites this paper
• Nanotherapy for Brain Tumor Drug Delivery

  2021cites this paper
• Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment

  2021influential citation
• Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.

  2021cites this paper
• Roles of Layilin in Regulation of Low-Density Lipoprotein Receptor in Malignant Glioma Cells

  2020cites this paper
• Progress and perspectives on nanoplatforms for drug delivery to the brain

  2020cites this paper
• Functional and Molecular Photoacoustic Computed Tomography Using Light Emitting Diodes

  2020cites this paper
• Neurotensin receptor 2 is induced in astrocytes and brain endothelial cells in relation to status epilepticus and neuroinflammation following pilocarpine administration in rats

  2020cites this paper
• Overcoming blood-brain barrier transport: Advances in nanoparticle-based drug delivery strategies.

  2020cites this paper
• Conjugation of Therapeutic PSD-95 Inhibitors to the Cell-Penetrating Peptide Tat Affects Blood–Brain Barrier Adherence, Uptake, and Permeation

  2020cites this paper
• Role of particle shape on efficient and organ-based drug delivery

  2020cites this paper
• Polymeric Nanoparticles for the Treatment of Malignant Gliomas

  2020cites this paper
• Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines

  2020cites this paper
• Nanotheranostic agents for neurodegenerative diseases.

  2020cites this paper
• Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB).

  2020cites this paper
• Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme.

  2020cites this paper
• Application of nano-based systems for drug delivery and targeting: a review

  2020cites this paper
• Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems

  2020cites this paper
• Target engagement and intracellular delivery of mono- and bivalent LDL receptor-binding peptide-cargo conjugates: implications for the rational design of new targeted drug therapies.

  2019cites this paper
• Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery

  2019cites this paper
• Neutrophil-mediated and low density lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts neuroprotective effects against ischemic stroke

  2019cites this paper
• Menthol-modified casein nanoparticles loading 10-hydroxycamptothecin for glioma targeting therapy

  2019cites this paper
• Receptor-mediated transportation through BBB

  2019cites this paper
• Development of a Novel DNA Oligonucleotide Targeting Low-Density Lipoprotein Receptor

  2019cites this paper
• Brain Cancer Receptors and Targeting Strategies

  2019cites this paper
• Nanotherapeutics Engineered to Cross the Blood-Brain Barrier for Advanced Drug Delivery to the Central Nervous System.

  2019cites this paper
• Dual and multi-targeted nanoparticles for site-specific brain drug delivery.

  2019cites this paper